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Summary 
Foot-and-mouth-disease (FMD) is endemic in Kenya where four serotypes (O, A, SAT 1 and SAT 2) of the 
virus are currently in circulation. Within 2010 and 2011, the National Laboratory recorded an increase in 
the number of FMD outbreaks caused by serotype O virus. The characteristics of these viruses were 
determined to ascertain whether these were independent outbreaks or one single strain spreading 
throughout the country. The sequences of the complete VP1 coding region were analyzed from viruses 
sampled within different areas of Kenya during 2010 and 2011. The results indicated that the 2010 and 
2011 outbreaks in Kenya were independent from each other. By comparison with earlier type O isolates 
from Eastern Africa, it was apparent that the outbreaks were caused by viruses from three different lineages 
of topotype EA-2 and a fourth virus strain belonging to topotype EA-4. The topotypes EA-1 and EA-3 were 
not detected from these outbreaks. Implications of these results for FMD control in Eastern Africa are 
discussed.  
 
Keywords: Kenya; foot-and-mouth-disease; serotype O FMDV; East Africa; topotype; outbreaks 
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Introduction 
Foot-and-mouth disease (FMD) affects both domestic and wild cloven-hoofed animals such as cattle, pigs, 
sheep, and goats plus more than 70 species of wildlife (Alexandersen and Mowat, 2005; Thomson et al., 
2003). The disease is clinically characterized by fever, lameness, and vesicular lesionsvesicles on the 
tongue, feet, snout, and teats of susceptible species (Kitching, 2002). FMD has been known since the 
sixteenth century as an important threat in the cattle industry and has continued to is be one of the world’s 
most economically important livestock diseases . Losses due to FMD can bewith indirect losses due to 
trade embargos embargos on livestock and livestock products or and direct oneeffects  such as reduced 
milk yields, weight loss, abortions, prenatal mortality and loss of cart power in draught animals (James and 
Rushton, 2002). Improved control of the diseasethe disease  may contribute to poverty reduction and 
increased economic growth in developing countries (Perry and Rich, 2007) such as Kenya where the 
disease is endemic.  
The causative agent of the disease, foot-and-mouth disease virus (FMDV), occurs in seven 
immunologically and genetically distinct serotypes O, A, C, Asia 1, SAT 1, SAT 2, SAT 3 and multiple 
variants exist within each serotype (Grubman and Morgan, 1986; Knowles and Samuel, 2003).  These 
serotypes can be distinguishedable both serologically and by nucleotide sequencing. Vaccination against 
one serotype does not cross-protect against other serotypes, , thus necessitating vaccination against all 
circulating each of the serotypes circulating.  in an area or an outbreak. FurthermoreAdditionally, FMDV 
has a high potential for genetic and antigenic variation,  thishencewhich createsing the need to constantly 
match vaccines to the circulating field viruses (Domingo et al., 2003). 
The FMDV genome is a positive-sense single-stranded RNA molecule with a length of approximately 8400 
nucleotides (nt) long that belongs to the genus Aphthovirus within the Picornaviridae family (Belsham, 
2005). The genome encodes a polyprotein which is processed to the virus structural proteins (SP) 
designated VP1 (1D), VP2 (1B), VP3 (1C), and VP4 (1A) and multiple non-structural (NS) proteins 
(Rueckert, 1984). Within the viral RNA, Tthe VP1 coding region has been found to beis the most variable, 
hence many studies of evolutionary relationships between FMDV strains and serotypes are based on VP1 
sequences have sequenced this part of the genome in order to determine and understand evolutionary 
relationships between FMDV strains and serotypes (Knowles and Samuel, 2003), and have. Based on these 
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VP1 sequences, the serotypes have been grouped the serotypes into various epidemiologically and 
genetically distinct regional clusters in different regions of the world defined as virus lineages and 
topotypes in accordance with intra-lineage and intra-topotype nucleotide identity ≥92.5 % and ≥85%, 
respectively (Knowles and Samuel, 2003; Samuel and Knowles, 2001a).  
Among the seven serotypes, FMDV O has been found to be dominant globally and has been responsible for 
some economically devastating outbreaks in countries which are normally free from FMDdisease-free such 
as the United Kingdom (Knowles et al., 2001; Samuel and Knowles, 2001b) and Japan (Hayama et al., 
2012; Sakamoto and Yoshida, 2002). Similarly, in the region of East Africa (EA) where the disease is 
endemic, serotype O has been responsible for most outbreaks. Several recent studies have characterized 
these FMDV O isolates in EA and recommended inclusion of a broader range of virus isolates in future 
analyses for a better approach to FMD control within the region (Ayelet et al., 2009; Balinda et al., 2010a; 
Habiela et al., 2010; Kasambula et al., 2012). These studies found four topotypes of this serotype namely, 
East Africa 1 (EA-1) to EA-4 circulating in this region with no evidence of additional introductions except 
for transboundary exchange of viruses between neighbouring countries within the region. In Kenya, most 
FMDV O strains isolated within the country since 2000 belong to topotypes EA-2, EA-3 and EA-4, while 
the locally produced vaccine that is currently in use is based on strain O K77/78 which was isolated in 1978 
and is classified within topotype EA-1 (Balinda et al., 2010a). The use of this vaccine may contribute to 
inadequate disease control, yet the FMD control policy in Kenya is to use locally produced vaccines and 
animal movement control. So far, the Directorate of Veterinary Services (DVS) has not received 
complaints or had records of FMDV O post-vaccination outbreaks although it lacks resources to undertake 
consistent post-vaccination monitoring (PVM). However, it relies on vaccine potency testing results 
(involving vaccination and challenge), generated by the state vaccine quality control laboratory that is 
independent from the producer.  
Apart from serotype O, other serotypes including A, SAT 1 and SAT 2 have also been recently in 
circulation (Namatovu et al., 2013), while previously, serotype C has also been identified within the region 
(Vosloo et al., 2002). However, serotype C was last isolated from Kenyan cattle in 2004 (Roeder, 2009; 
Sangula et al., 2011).  
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During 2010 and 2011, there was an increase in the recorded number of FMD outbreaks in Kenya. From 
the use of virus isolation and antigen detection proceduresusing enzyme linked immunosorbent assays 
(ELISAs), the Kenyan National Laboratory found that 105 of the 265 districts in the country (40%) had 
cases of FMD between January and December 2010 and this pattern continued into 2011. Among these, 74 
districts (70%) had been affected by serotype O FMDV, the highest annual occurrence of this serotype 
since the year 2000. It was not known whether these were independent outbreaks or if each case was part of 
a single outbreak that quickly spread to the various districts of the country. In a comparable occurrence, 
multiple FMD outbreaks were reported to have taken place within a short period of time during 2008-2009 
in neighboring Uganda were shown to belong to a single outbreak that rapidly spread and affected large 
areas (Kasambula et al., 2012).  
Recently, Balinda et al., (2010a) sequenced the VP1 coding region of 46 viruses of serotype O collected in 
Kenya between 1964 and 2008 and recommended a more widespread collection of viruses for appropriate 
vaccine development and better regional FMD control strategies. Now, in this study, the VP1 coding region 
sequences of recently (2010-2011) circulating serotype O FMDVs from various geographical areas of 
Kenya have been determined and analysed. The study was aimed at determining the characteristics of these 
VP1 sequences in order to understand the recent outbreak patterns.  
Materials and Methods 
Source of viruses used in this study  
Epithelial samples were selected from the national FMD laboratory (FMDL), Embakasi, Kenya virus 
repository. These were field samples collected, from suspected clinical cases of FMD in cattle by 
goverment District Veterinary Officers (DVOs), between February 2010 and September 2011 for the 
purpose of serotype identification and mapping to guide FMD control strategies. The samples were 
preserved in 50% glycerol-phosphate buffered saline (PBS) and transported on ice, in the shortest time 
possible, to the FMDL, where they were subsequently aliquoted and preserved at -20oC. Virus isolation in 
Baby Hamster Kidney (BHK) cells and FMDV antigen detection using enzyme linked immunosorbent 
assays (ELISAs) were routinely performed according to procedures in the OIE manual (OIE, 2012). For the 
purpose of this study, the samples were selected taking regional representation and quality of the material 
into consideration. Thus samples were selected from different districts representing the eight administrative 
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regions (provinces) of the country, namely: Western, Nyanza, Rift-Valley, Central, Nairobi, Eastern, North-
Eastern and Coast (Fig. 1). Viruses from a total of 35 samples collected between 1998 and 2011 have been 
isolated and sequenced in this study at the National Veterinary Institute, Technical University of Denmark, 
Lindholm (DTU Vet) and The Pirbright Institute, U.K. (Table 1). The sequences were analysed together 
with others from a previous study (Balinda et al., 2010a) and from the public sequence databases (Table 1).  
Virus Isolation 
At Lindholm and in Pirbright, for the purpose of sequencing, viruses were re-isolated on primary bovine 
thyroid (BTY) cells according to the OIE manual (OIE, 2012). Briefly, epithelia preserved in 50% glycerol-
PBS at -20°C, were thawed at room temperature, weighed and ground using sterile sand, with a mortar and 
a pestle, in Eagles minimum essential media supplemented with protein hydrolysate, 2% fetal calf serum 
and antibiotics to make a 10% suspension. The suspensions were inoculated onto primary bovine thyroid 
(BTY) cells for 1 hour, followed by a change of media and then continued incubation. The cultures were 
observed for cytopathic effect (CPE) after 24 and 48 hours and harvested when CPE developed. Negative 
samples were further passaged onto fresh cells for another 48 hours.  
Total RNA Extraction and cDNA Synthesis   
At The Pirbright Institute, total RNA extraction and cDNA synthesis were done as described by Ayelet et 
al. (2009) and Habiela et al. (2010), while at  DTU Vet these were done as follows: 
 Viral RNA was extracted from CPE positive cell culture harvests using the QIAmp® viral RNA mini kit 
(Qiagen) following the viral RNA mini spin protocol as described by the manufacturer, using 60 µl of AVE 
buffer for elution (as supplied) and the RNA was stored at -80°C.  
To synthesize cDNA, the RT master mix was made using PE Biosystems TaqMan RT reagents (part N808-
1234) in accordance with the manufacturer’s instructions. Briefly, for each reaction, 1.5 µl of 10x TaqMan 
RT buffer (500 mM KCl, 100 mM TrisHCl, pH 8.3), 3.3 µl of 25 mM MgCl2, 3.0 µl of dNTP (2.5 mM 
each), 0.5 µl of 50 µM random hexamers, 0.3 µl of RNase inhibitor (20U/µl) and 0.375 µl of MultiScribe 
reverse transcriptase (100 U/µl, Moloney RT) were used making a total of 9 µl per reaction. RNA samples 
(6 µl) were added to the master mix to make 15 µl per reaction and incubated at 48°C for 45 min, and 95°C 
for 5 min. The cDNA products were stored at -20°C. 
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Real time RT-PCR to detect FMDV RNA 
Quantitative RT-PCR was performed using TaqMan® Universal 2X PCR Master Mix (PE Biosystems). The 
TaqMan PCR was run as described previously (Reid et al., 2003) using the FMDV MultiII IRES primers 
(FMDV Multi II forward primer and FMDV Multi II reverse primer) and FMDV Multi II-288 probe 
(FAM-labelled). The reaction mixtures (25 µl) contained 2.25 µl of 10 pmol/ µl forward primer, 2.25 µl of 
10 pmol/ µl reverse primer, 1 µl of 5 pmol/ µl probe and 12.5 µl of the universal master mix. This 18 µl of 
this master mix was mixed with 7 µl cDNA template and t. The tubes were sealed with optical caps and, 
then incubated in a Mx3005P cycler (Stratagene) for 50 cycles; 50°C 2min (UNG digest), 95°C 10min 
(heat activation of TaqGold) and 50 x ( 95°C 15s  and  60°C 60s), then held at 4°C.  
RT-PCR to amplify and sequence FMDV VP1 coding sequence 
 At The Pirbright Institute, these methods were done as described by Ayelet et al. (2009) and Habiela et al. 
(2010), while at  (DTU Vet) as follows: 
Samples which were shown to contain significant amounts of FMDV RNA (Ct <32) (Shaw et al., 2007) 
were selected for VP1 coding region amplification. The cDNA sequence was amplified using reverse 
primer 11-FPN 28 (5’ GGGCCCAGGGTTGGACTC 3’) and forward primer 11-FPN 29 (5’ 
GCIGCIGACTACGCITACACYGC 3’) (note, I = inosine and Y = C and T). These primer sequences were 
flanked the region betweenfound between positions nt 3936 and 3169 inof the virus genome respectively 
and includesing the entire VP1 coding region. The primers were and designed with reference to strain O 
UKG 35/2001, GenBank accession number AJ53914 (Mason et al., 2003). 
The reaction mixture for each amplification (50 µl) comprised RNAase free water (25µl), 5.0 µl 10X PCR 
buffer, 4.0 µl of 25 mM MgCl2, 0.4 µl of 10 mM dNTPs, 5.0 µl of each primer (10 pmol/µl), and 5.0 µl 
cDNA template andplus 20 U of AmpliTaq Gold® DNA polymerase (Applied Biosystems). The PCR was 
run in a thermocycler (Gene Amp® PCR system 3700 version 3.0 - Applied Biosystems) using the 
touchdown method for 1 cycle; 95°C 5min, 1 cycle; 95°C 15s, 5 cycles; 55°C 30s, 1 cycle; 72°C 1 min 
20s, 40 cycles; (95°C 15s, 50°C 30s, 72°C 1 min.20s), 1 cycle; 72°C 7 min and 4°C holding. 
The PCR products (ca. 885 bp) were viewed by electrophoresis on 1.5 % agarose gels (Seakem GTG 
agarose in 1 X TAE - low EDTA buffer) at 120 volts for 1 hour in parallel with a molecular weight marker 
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ФX 174-RF DNA (Amersham, Biosciences). Purification of the PCR products was achieved using the 
QIAquick PCR purification kit (Qiagen). Products for cycle sequencing were quantified using a 
NanoDrop® 1000 Spectrophotometer  (Thermo Scientific) and for each reaction, 10 - 13 ng of amplicon 
was used. Cycle sequencing, in both directions, was performed using the Big dye Terminator V 3.1 kit 
(Applied Biosystems) and run on an automated DNA Sequencer (ABI PRISM 3700; Applied Biosystems). 
Sequence Analysis 
The nucleotide sequences in this study were edited using SeqMan Pro software (Lasergene package, 
DNAstar, Inc.). Serotypes of the generated sequences were identified and compared with previous data 
using the Basic Local Alignment Search Tool (BLAST) (www.ncbi.nlm.nih.gov). The sequences were 
aligned by MUSCLE incorporated in MEGA software version 5.05 (Tamura et al., 2011) and trimmed to 
639 nucleotides comprising the complete VP1 coding region.  
Substitution models were determined in the MEGA software. Codon positions included were 1st+2nd+3rd. 
Maximum Likelihood fits of 24 different nucleotide substitution models were estimated and Akaike 
Information Criterion (AIC) estimated. Non-uniformity evolution rates were modeled using discrete 
gamma distribution (G). Thus, Tamura Nei substitution model with gamma distribution and invariable rates 
(I) (TN93+G+I) was chosen as the best that describes the substitution pattern (Tamura et al.., 2011). The 
evolutionary history was inferred using the Neighbor-joining method (Saitou and Nei, 1987) and a 
bootstrap consensus tree estimated from 1000 replicates (Felsenstein, 1985) taken to represent the 
evolutionary history of the taxa analyzed.  
The sequences in this study were compared to selected serotype O Kenyan isolates from 1978 to 2009 and 
to isolates obtained from neighbouring countries during 1986-2009, using two 1983 isolates from Hong 
Kong and Indonesia as outgroups. The taxa were grouped into topotypes defined by an intra-topotype 
nucleotide identity within the VP1 coding sequence of >85% (Knowles and Samuel, 2003; Samuel and 
Knowles, 2001a).  
Results 
Thirty five FMD viruses wereall having been successfully isolated ion celltissue culture and tested positive 
for serotype O FMDV usingon antigen ELISAs. Virus harvests were also shown to contain significant 
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amounts of FMDV RNA by real time RT-PCR assays (Ct <32). , hence were selected for The VP1 coding 
region from each of these samples was amplified by RT-PCRcation and subsequentlysequenced. BLAST 
searches usingof the VP1 coding region of these sequences confirmed that these were of serotype O FMDV 
in each case. Generally, aApart from one, all the other 2010-2011 viruses sequenced in this study were 
distributed among three distinct lineages (with each lineage having ≥7.5% differences in nucleotide 
sequence within the VP1 coding region) and were, classified within the EA-2 topotype (labeled as lineages 
A, B and C in Fig. 2). In a Neighbor-joining tree, tThese lineages grouped, in a Neighbor-joining tree, 
together with viruses from Uganda that had been collected in 2004-2006 (Fig. 2). The one other virus 
(K72/2010) belonged to the EA-4 topotype (labeled as lineage D in Fig. 2), originated from district 14 (Fig. 
1) and grouped together with some earlier Ethiopian and Ugandan viruses. This virus made up an 
independently evolving sub-lineage within this topotype with nucleotide differences of about 11% and 9% 
compared to the Ethiopian and Ugandan viruses, respectively. 
Lineage A, within the EA-2 topotype (Fig. 2), incorporated nine viruses from this study, including 
K31/2011 and K249/2010. These viruses had about 97% intra-topotype nucleotide identity within the VP1 
coding sequence. They were collected between December 2010 and April 2011 (Table 1) from six districts 
(Siaya, Nyandarua, Thika, Baringo, Rongai and Koibatek) located in three different provinces (Central, Rift 
Valley and Nyanza) (Fig. 1). This group differed in their nucleotide sequence from lineages B and C by 
about 12 % and 10 - 11% respectively. 
Lineage C, in the EA-2 topotype, included nine isolates from both 2010 and 2011, including K224/2011 
from Kinango in Coast province and K98/2011 that grouped together with several others obtained from 
several districts around the southern and central parts of the Rift Valley province of the country (Fig. 1). 
They clustered together with others collected from Coast province in 2010, Central in 2005 and Nyanza in 
2009. This lineage also contained three independently evolving sub-lineages (Fig. 2) with about 6% 
nucleotide differences among them.  
The third lineage (B) within the EA-2 topotype included only one isolate fromin this study (K251/2010) 
(Fig. 2). This virus was collected from district 3 in the Western province of the country, near the border 
with Uganda (Fig. 1). It had 93% nucleotide identity to viruses collected in 2002 from the same province in 
Kenya and 91-92% identity with those from Eastern Uganda between 2002 and 2009 and about 99% 
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nucleotide identity with the 2011 viruses from the same region in Uganda (data not shown). However, this 
lineage had about 12% nucleotide difference from viruses in lineage A and about 12% from those in 
lineage C (within the VP1 coding region). 
Discussion 
This study has analyzed FMDVs isolated from serotype O FMD outbreaks in all the eight provinces of 
Kenya from ebruary 2010 until September 2011 that were responsible for the serotype O FMD outbreaks 
during this period. Three independently evolving lineages belonging to topotype EA-2 were the most 
commonly occurring and found to be responsible for the majority of these recent outbreaks in Kenya. In 
addition, this study showed that there was another virus strain belonging to topotype EA-4 circulating in 
2010 and that none of the recent viruses belonged to topotypes EA-1 and EA-3. Unlike two studies recently 
undertaken in neighboring Uganda  (Kasambula et al., 2012;  A. Namatovu , G. J. Belsham, C. 
Ayebazibwe, M.T. Dhikusooka, S. N. Wekesa, H. R. Siegismund, V. B. Muwanika, K. Tjørnehøj, 
unpublished results) which found only closely related serotype O FMDVs causing outbreaks, this study 
found different lineages even between neighbouring districts, indicative of different recent common 
introductions of the viruses. In addition, the different lineages were spread in several provinces of the 
country, suggestive of widespread transmission of the viruses within the country. 
Viruses in lineage A consisted of several isolates that occurred late in 2010 and early 2011 that were 
distributed across 3 different regions of the country (Nyanza, Rift valley and Central). This group seems to 
have evolved from one recent common ancestor and within five months (December 2010 to April 2011), it 
had rapidly spread across a wide area within these three different regions of Kenya. In particular, virus 
K24/2011 from Thika and K31/2011 from Kisumu were collected almost concurrently about 380 km road 
distance apart. yet they occurred almost concurrently. Furthermore, the period of Tthis occurrence 
coincided with two major national holidays and festive seasons (Christmas and Easter), during which 
animal movements for sale and slaughter are usually increased, which may explain the rapid spread. 
Considering that FMD control measures in Kenya mainly rely on animal movement control and 
vaccination, and that the virus had spread widely within a short period, it is likely that the control systems 
in the country were breached during this period. there were loopholes in the control systems in the country 
at that time.  Similarly, lineage C viruses appear to have circulated across three different regions of Kenya 
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that are also widely separated. Viruses within this lineage were obtained from different districts within the 
southern and central parts of the Rift Valley and the coastal region. In addition, it is noteworthy that this 
lineage contained three independently evolving sub-lineages, two of them in the Rift Valley and one in the 
Coast region. These observations are suggestive of inadequate countrywide disease control measures that 
ought to be investigated and addressed by the relevant authorities and stakeholders. 
The Western regions of Kenya and Eastern parts of Uganda have traditionally been associated with 
movement of animals across the borders for various reasons including trade, grazing and cattle raiding. 
This probably is the reason why lineage B, including K251/2010 from this study collected in December 
2010 from Kwanza district in western Kenya was confined toobserved in these two countries. This virus is 
closely related to an earlier virus from the same region in Kenya near the border with Uganda and other 
earlier viruses from Eastern Uganda. Furthermore, two other viruses recently isolated from Kumi and 
Bukedea districts in Eastern Uganda in March 2011 have been found to be closely related to this virus (A. 
Namatovu, G. J. Belsham, C. Ayebazibwe, M.T. Dhikusooka, S. N. Wekesa, H. R. Siegismund, V. B. 
Muwanika and K. Tjørnehøj, unpublished results). This is not surprising because, even though Kenya and 
Uganda are both East African countries, they have varying levels of disease control and biosecurity 
measures. Nevertheless, both countries use animal movement control as one of the methods of disease 
control. These findings have therefore confirmed the transboundary mobility of serotype O as observed in a 
previous studies (Balinda et al., 2010a), hence necessitating enhancement of border surveillance and 
harmonization of livestock trade and animal movement regulations between the two countries if the much 
desired regional control of FMD is to be achieved. 
Viruses belonging to topotype EA-4 have not been reported in Kenya previously but this topotype has been 
found in Ethiopia in 2005 (Ayelet et al., 2009) and earlier in Uganda in 1998-1999 (Ayelet et al., 2009; 
Balinda et al., 2010b). The identification of this topotype in Kenya in this study, unlike in previous studies, 
is probably due to the inclusion of a wider geographical representation of isolates in the present analysis 
that has additionally included the North-Eastern, Nyanza and Coastal provinces of Kenya. This finding is 
suggestive of a probable recent incursion of EA-4 into Kenya as an emerging topotype that needs to be 
thoroughly investigated. Consequently, this reveals that border disease control measures should be 
scrutinized and possible problems addressed. On the other hand, this virus may have been circulating 
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earlier within the country undetected, therefore raising the need for regular surveillances and virus 
characterization to ascertain the strains of viruses in circulation. 
By 2008, the EA-2 topotype had been found to be mainly confined to Uganda and Kenya for about ten 
years (Balinda et al., 2010b). This study has found that this topotype was the most commonly occurring in 
Kenya. This observation is largely consistent with previous studies in the East African region including 
Ethiopia, Kenya and Uganda (Ayelet et al., 2009; Balinda et al., 2010a) which indicated that recent FMDV 
O viruses in Kenya and Uganda are all grouped in topotype EA-2 and that there are hardly any incursions 
from outside the region. Apart from Kenya and Uganda, the EA-2 topotype has also been found in Burundi 
(1980, 1999 and 2003), the Democratic Republic of the Congo (2006 and 2010), Rwanda (1998 and 2004), 
Tanzania (1980, 1984, 1985, 1996, 1998, 2004, 2009 and 2012), northern Malawi (1998) and northern 
Zambia (2000 and 2010) (N.J. Knowles, unpublished data; Balinda et al., 2010a; Di Nardo et al., 2011) 
suggesting that EA-2 has been widespread in this region at least since the early 1980’s. This is not 
unexpected as earlier studies have found these countries do rely strongly on one another for livestock trade 
(Rweyemamu et al., 2008) and pastures especially for the nomadic communities around the national 
borders. However, studies on the distribution of topotype EA-2 in the region as well as the other topotypes 
ought to be extended to other countries such as Burundi, Rwanda, Democratic Republic of Congo (DRC), 
Somalia and South Sudan where the FMD epidemiological situation is unclear  
Topotype EA-3 was last documented in Kenya in 1999 (KEN/1/1999) and in the same year in Uganda 
(Balinda et al., 2010a), while in the recent past it has been mainly confined to Eritrea, Ethiopia and Sudan 
(Ayelet et al., 2009; Habiela et al., 2010). However,  Di Nardo et al., (2011) have recently determined 
livestock movement patterns in the region indicating movements from Ethiopia, Sudan and Somalia into 
Kenya that may pose a risk of disease transmission in that direction. As a result the current confinement of 
EA-3 to these countries may not remain constant since this topotype could easily move back into Kenya if 
control measures at the borders are inefficient. Moreover, there is need for more surveillance in the 
Northern and North-Eastern parts of Kenya neighbouring these countries to ascertain the absence of this 
topotype within the country. 
The majority of East African countries, including Kenya, rely on vaccination and animal movement control 
for FMD control measures. However, the current vaccine strain K77/1978 belongs to topotype EA-1 and 
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has been used since 1981, not only in Kenya but also by several countries in the region such as Uganda, 
Ethiopia, Sudan, Burundi and Somalia. This study and other recent studies in Kenya  (Balinda et al., 
2010a), in Uganda  (Kasambula et al., 2012; A. Namatovu, G. J. Belsham, C. Ayebazibwe, M.T. 
Dhikusooka, S. N. Wekesa, H. R. Siegismund, V. B. Muwanika and K. Tjørnehøj, unpublished results), in 
Ethiopia (Ayelet et al., 2009) and in Sudan (Habiela et al., 2010) have found that the VP1 coding region of 
this vaccine which belongs to topotype (EA-1) strain has more than 15% nucleotide divergence, within the 
VP1 coding region, from the majority of the currently circulating strains.  The antigenic relationship 
between this vaccine strain and FMDV field strains has not been established, yet, as described by Paton et 
al., (2005), appropriate vaccine strain selection is essential for FMD control programs that depend on 
vaccination. Therefore, although vaccination failures have not been recently recorded, there is a need to 
undertake consistent PVM and vaccine matching.  
In conclusion, the existing systems to control the spread of FMDV within Kenya and the entire region of 
Eastern Africa seem inadequate and require re-evaluation. Therefore, there is need for increased 
surveillance, better disease control measures at source and efficient animal movement control both within 
the country and across the borders. Additionally, it is necessary to undertake studies to assess the 
effectiveness of the current serotype O vaccine strains using virus neutralization tests or ELISAs as 
recommended by OIE (OIE, 2012). 
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List of figures and tables 
Fig.  1.  Map of Kenya showing geographical districts and administrative regions (underlined) from which 
2010-2011 samples analyzed in this study were collected. The encircled numbers correspond to the listing 
in Table 1. 
Fig.  2.  A Neighbor-joining tree based on nucleotide sequences of the VP1 coding region of serotype O 
viruses from Kenya in comparison with other East African topotypes. (•) indicates the 2010-2011 viruses in 
this study and (▲) the current vaccine strain. The values on the nodes show posterior probabilities. The 
encircled letters A-D show the lineages in which the recent Kenyan isolates group. EA -1 to 4 are the East 
Africa topotypes that have been found in Kenya. 
Table 1. List of serotype O FMD viruses analyzed in this study, including viruses collected in Kenya 
during 2010-2011 and sequenced in this study, the current vaccine strain and other older viruses from 
Kenya and rest of the Eastern Africa region.  
a
 K and KEN - prefixes used in FMDL Embakasi and at the Pirbright Institute, respectively for Kenyan 
isolates. b Current vaccine strain.  
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No. Virus Ref. number
a  Date collected Country/Region/ District Accession No. Topotype Reference 
1 K182/2010 26/08/2010 Kenya/Rift Valley/Laikipia KF207885 EA-2 This Study 
2 K241/2010 17/12/2010 Kenya/Central/Thika-West KF207886 EA-2 This Study 
3 K251/2010 29/12/2010 Kenya/Western/Kwanza KF207887 EA-2 This Study 
4 K24/2011 04/02/2011 Kenya/Central/Thika KF207881 EA-2 This Study 
5 K31/2011 12/02/2011 Kenya/Nyanza/Siaya KF207882 EA-2 This Study 
6 K38/2011 02/03/2011 Kenya/Rift Valley/Rongai KF207883 EA-2 This Study 
7 K47/2011 08/04/2011 Kenya/Rift Valley/Baringo KF207884 EA-2 This Study 
8 KEN/1/2011 (K10/11) 12/01/2011 Kenya/Central/Thika-West KF135289 EA-2 This Study 
9 KEN/5/2011 (K32/11) 15/02/2011 Kenya/Central/Nyandarua KF135290 EA-2 This Study 
10 KEN/6/2011 (K33/11) 19/02/2011 Kenya/Rift Valley/Rongai KF135291 EA-2 This Study 
11 KEN/15/2011 (K91/11) 18/09/2011 Kenya/Rift Valley/Gilgil KF135292 EA-2 This Study 
12 KEN/16/2011 (K98/11) 22/09/2011 Kenya/Rift Valley/ Masaba  KF135293 EA-2 This Study 
13 UGA/APAC/2009 2009 Uganda/North/Apac JN974309 EA-2 
Kasambula et al., 
2012 
14 
KEN/100/2010 
(K72/10) 28/04/2010 Kenya/Rift Valley/ Eldoret  KF135281 EA-4 This Study 
15 
KEN/137/2010 
(K152/10) 06/07/2010 Kenya/Rift Valley/Transmara KF135282 EA-2 This Study 
16 
KEN/145/2010 
(K211/10) 19/10/2010 Kenya/Rift Valley/Kericho KF13528 EA-2 This Study 
17 
KEN/146/2010 
(K220/10) 16/11/2010 Kenya/Rift Valley/Nakuru  KF135284 EA-2 This Study 
18 
KEN/148/2010 
(K222/10) 17/11/2010 Kenya/Rift Valley/Rongai KF135285 EA-2 This Study 
19 
KEN/150/2010 
(K224/10) 22/11/2010 Kenya/Coast/Kinango KF135286 EA-2 This Study 
20 
KEN/151/2010 
(K233/10) 01/12/2010 Kenya/Rift Valley/Kajiado KF135287 EA-2 This Study 
21 
KEN/152/2010 
(K249/10) 23/12/2010 Kenya/Rift Valley/Koibatek KF135288 EA-2 This Study 
22 KEN/6/2009 (K16/09) 01/02/2009 Kenya/Rift Valley/Kipkelion KF135279 EA-2 This Study 
23 KEN/10/2009 (K29/09) 01/02/2009 Kenya/Nyanza/Bondo KF135280 EA-2 This Study 
24 HKN/6/83 1983 Hong Kong AJ294919 CATHAY Knowles et al., 2001 
25 ISA/8/83 1983 Indonesia AJ303503 ISA-1 
Samuel and Knowles, 
2001 
26 K1/2008 08/01/2008 Kenya/Nairobi/Nairobi-East HM756635  EA-2 Balinda et al., 2010 
27 KEN/3/2008 (K4/08) 23/01/2008 Kenya/Central/Thika KF135276 EA-2 This Study 
28 KEN/4/2008 (K6/08) 06/02/2008 Kenya/Rift valley/Nakuru KF135277 EA-2 This Study 
29 K11/2008 20/02/2008 Kenya/Central/Kiambu-West HM756637  EA-2 Balinda et al., 2010 
30 K14/2008 22/02/2008 Kenya/Rift Valley/Baringo HM756638  EA-2 Balinda et al., 2011 
31 K31/2008 05/05/2008 Kenya/Rift Valley/Kajiado HM756639  EA-2 Balinda et al., 2012 
32 K32/2008 05/05/2008 Kenya/Central/Thika HM756640  EA-2 Balinda et al., 2013 
33 
KEN/36/2008 
(K104/08) 01/12/2008 Kenya/Rift Valley/Molo KF135278 EA-2 This Study 
34 K82/2007 01/10/2007 Kenya/Central/Murang'a HM756634  EA-2 Balinda et al., 2010 
35 K30/2007 18/06/2007 Kenya/Rift Valley/Laikipia HM756632 EA-2 Balinda et al., 2010 
36 K2/2007  11/01/2007 Kenya/Central/Kiambu HM756629 EA-2 Balinda et al., 2010 
37 KEN/12/2007 (K57/07) 23/07/2007 Kenya/Eastern/Imenti-North KF135275 EA-2 This Study 
38 KEN/4/2005 (K7/05) 26/01/2005 Kenya/Central/Nyeri KF135272 EA-2 This Study 
39 KEN/14/2005 (K48/05) 21/07/2005 Kenya/Central/Kiambu KF135273 EA-2 This Study 
40 KEN/27/2005 (K46/05) 15/07/2005 Kenya/Central/Kiambu KF135274 EA-2 This study 
41 
KEN/24/2004 
(K139/04) 30/07/2004 Kenya/Central,/Murang'a KF135269 EA-2 This study 
42 
KEN/29/2004 
(K170/04) 21/10/2004 Kenya/Eastern,/Machakos KF135270 EA-2 This study 
43 
KEN/30/2004 
(K176/04) 24/12/2004 
Kenya/North-
Eastern/Marsabit KF135271 EA-2 This Study 
44 KEN/3/2002 (K56/02) 29/07/2002 Kenya/Western/Busia KF135268 EA-2 This Study 
Table 1. List of serotype O FMDV viruses analyzed in this study, including viruses collected in Kenya during 2010-2011 and 
sequenced in this study, the current vaccine strain and other older viruses from Kenya and rest of the Eastern Africa region.  
 
 
Page 20 of 23
Transboundary and Emerging Diseases - submitted manuscript
Transboundary and Emerging Diseases - submission proof
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
45 KEN/7/98 (K30/98) 1998 Kenya KF135266 EA-3 This Study 
46 KEN/1/99 (K1/99) 1999 Kenya KF135267 EA-3 This Study 
47 K50/2006 21/07/2006 
Kenya/Rift Valley/Uasin 
Gishu HM756626 EA-2 Balinda et al., 2010 
48 K31/2005  27/05/2005 Kenya/Rift Valley/Laikipia HM756623 EA-2 Balinda et al., 2010 
49 K79/2002 01/10/2002 Kenya/Rift Valley/Nakuru HM756616 EA-2 Balinda et al., 2010 
50 K114/1987 1987 Kenya HM756594 EA-2 Balinda et al., 2010 
51 K101/1980 1980 Kenya HM756589 EA-2 Balinda et al., 2010 
52 K83/1979 1979 Kenya/Central/Nyeri AJ303511 EA-1 
Samuel and Knowles, 
2001 
53 K77/1978b 1978 Kenya/Rift Valley/Nakuru HM756588 EA-1 Balinda et al., 2010 
54 U97/1999 1999 Uganda HM756604 EA-2 Balinda et al., 2010 
55 UGA/5/96 1996 Uganda AJ296327 EA-1 
Samuel and Knowles, 
2001 
56 ETH/27/2007 01/12/2007 Ethiopia FJ798139 EA-3 Ayelet et al., 2009 
57 ETH/58/2005 20/04/2005 Ethiopia FJ798141 EA-4 Ayelet et al., 2009 
58 ETH/60/2005 20/04/2005 Ethiopia FJ798143 EA-4 Ayelet et al., 2009 
59 ETH/1/79 1979 Ethiopia HM211077 EA-2 Balinda et al., 2010 
60 K56/1995 1995 Kenya HM756601 EA-2 Balinda et al., 2010 
61 UGA/17/98 1998 Uganda HM211075 EA-2 Balinda et al., 2010 
62 SUD/26/2004 2004 Sudan GU566054 EA-3 Habiela et al., 2010 
63 SUD/1/99 1999 Sudan DQ165076 EA-3 Habiela et al., 2010 
64 SUD/2/86 1986 Sudan DQ165075 EA-3 Habiela et al., 2010 
65 U18/2006 2006 Uganda/Mpigi HM756627 EA-2 Balinda et al., 2010 
66 U12/2005 2005 Uganda/Wakiso HM756625 EA-2 Balinda et al., 2010 
67 U17B/2004 2004 Uganda/Hoima HM756620 EA-2 Balinda et al., 2010 
a
 K and KEN are prefixes used in FMDL Embakasi and at the Pirbright Institute, respectively for Kenyan 
isolates; b Current vaccine strain. 
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Fig.  1.  Map of Kenya showing geographical districts and administrative regions (underlined) from which 
2010-2011 samples analyzed in this study were collected. The encircled numbers correspond to the listing in 
Table 1.  
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Fig.  2.  A Neighbor-joining tree based on nucleotide sequences of the VP1 coding region of serotype O 
viruses from Kenya in comparison with other East African topotypes. (•) indicates the 2010-2011 viruses in 
this study and (▲) the current vaccine strain. The values on the nodes show posterior probabilities. The 
encircled letters A-D show the lineages in which the recent Kenyan isolates group. EA -1 to 4 are the East 
Africa topotypes that have been found in Kenya.  
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